Translational gaps on the psychiatry/analgesic potential of CCK2r antagonists
Preclinical evidence | Clinical trials | ||||
---|---|---|---|---|---|
Compound (dosage) length | Outcomes | References | Compound (dosage) length | Outcomes | References |
CI-988 (0.001–10.0 mg/kg, i.p.)Acute | Anxiolytic-like action in rats elevated the X-maze, rat social interaction test, and mouse light/dark shuttle box | [208] | CI-988 (300 mg/day, thrice daily)Four weeks | No anxiolytic effect in general anxiety disorder | [23] |
CI-988 (100 mg/day, thrice daily)Six weeks | No anxiolytic effect in panic disorder | [25] | |||
L-365,260 (3.2, 10, and 32 mg/kg, i.p.)Acute | Antipanic-like effects in rats receiving brain stimulation in the dorsal PAG | [209] | L-365,260 (30 mg/day, four times daily)Six weeks | No anxiolytic effect in panic disorder | [24] |
CI-988 and L-365,260 (8.9, 0.16, and 0.25 μmol/kg, i.p.)Acute | Anxiolytic-like action in rats elevated the X-maze | [210] | L-365,260 (10–50 mg)Acute | CCK-4 panicogenic effects are antagonized by L-365,260 in panic disorder patients | [211] |
L-365,260 (0.1 and 0.5 mg/kg, s.c.)Acute | Enhancement of the analgesia induced by a submaximal dose of morphine | [212] | L-365,260 (10 mg and 40 mg thrice daily)Two weeks | L-365,260 fails to augment morphine-induced analgesia in chronic neuropathic pain | [26] |
i.p.: intraperitoneal; s.c.: subcutaneous. PAG: periaqueductal grey; CCK-4: cholecystokinin tetrapeptide
SJB: Conceptualization, Investigation, Methodology, Validation, Writing—original draft, Writing—review & editing.
Not applicable.
Santiago J. Ballaz, who is the Guest Editor of Exploration of Drug Science, had no involvement in the decision-making or the review process of this manuscript.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.